
STAAR Surgical (STAA) Stock Forecast & Price Target
STAAR Surgical (STAA) Analyst Ratings
Bulls say
Staar Surgical Co. possesses a robust market position in the ophthalmic surgical product segment, predominantly through its innovative implantable lenses used in refractive and cataract surgeries. The company demonstrates strong sales growth driven by the increasing demand for its Implantable Collamer lenses (ICL) and intraocular lenses (IOL), which cater to an expanding global population requiring vision correction. Additionally, Staar's strategic focus on developing advanced delivery systems and maintaining a dedicated niche within the ophthalmic market supports a positive outlook, despite facing competition from larger companies with more substantial financial resources.
Bears say
Staar Surgical faces potential challenges that could adversely affect its financial performance, primarily due to competitive pricing pressures from larger manufacturers, which may compress gross margins. Additionally, ongoing changes in healthcare policies and reimbursement reductions for age-related surgical products, such as intraocular lenses (IOLs) for cataracts, could hinder revenue growth. Furthermore, the risk associated with regulatory approvals for its product pipeline raises concerns about the company's capacity to expand its implantable collamer lens (ICL) market share.
This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.
STAAR Surgical (STAA) Analyst Forecast & Price Prediction
Start investing in STAAR Surgical (STAA)
Order type
Buy in
Order amount
Est. shares
0 shares